Skip to main content
. 2016 Jan 20;36(3):1008–1018. doi: 10.1523/JNEUROSCI.2768-15.2016

Table 1.

PTN subject characteristics

Subject Age (years) Gender Pain duration (years) Pain intensity (VAS) Location Analgesic medication BDI PCS
1 51 Male 3.5 2.1 Right None 6 10
2 47 Female 5 1.1 Left None 24 47
3 52 Female 1.5 6.9 Bilateral Oxycodone hydrochloride, paracetamol 18 29
4 55 Female 2 5.2 Left Docusate sodium; sennosides, amitriptyline, gabapentin, oxycodone, paracetamol 21 25
5 42 Female 11 4.8 Right Carbamazepine 34 36
6 54 Female 6.5 1.6 Right Amitriptyline 9 20
7 44 Female 2 6.4 Left None 11 15
8 41 Female 3.5 4.0 Left None 6 11
9 67 Female 14 8.4 Left None 4 29
10 43 Male 16 5.8 Left Desvenlafaxine 5 9
11 44 Female 1.5 1.2 Right Ibuprofen, codeine phosphate, paracetamol 19 25
12 65 Female 7 2.5 Left Amitriptyline, paracetamol 6 11
13 50 Female 7 0.5 Right None 6 2
14 67 Female 20 4.2 Right Thyroxine sodium, rosuvastatin, venlafaxine, pregabalin, phenylethylamine, ergotamine 32 18
15 67 Female 3 8.4 Left None 6 5
16 43 Male 9 5.8 Left Desvenlafaxine 30 29
17 44 Female 7.5 1.2 Right None 5 35